PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,342,175 | -53.3% | 280,500 | -25.7% | 0.02% | -58.1% |
Q2 2023 | $5,018,090 | +105.0% | 377,300 | +78.5% | 0.04% | +87.0% |
Q1 2023 | $2,447,294 | +446.9% | 211,338 | +286.4% | 0.02% | +475.0% |
Q4 2022 | $447,446 | -11.4% | 54,700 | -37.2% | 0.00% | 0.0% |
Q3 2022 | $505,000 | -65.1% | 87,125 | -69.0% | 0.00% | -88.6% |
Q4 2019 | $1,445,000 | +3702.6% | 280,960 | +2709.6% | 0.04% | +600.0% |
Q4 2016 | $38,000 | -87.1% | 10,000 | -76.1% | 0.01% | -92.4% |
Q2 2016 | $295,000 | +247.1% | 41,859 | +318.6% | 0.07% | +88.6% |
Q1 2016 | $85,000 | – | 10,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |